Home » Topics » BioWorld Science

BioWorld Science
RSS

J2H Biotech identifies new PROTACs for NSCLC

April 5, 2022

Betta Pharmaceuticals presents new CD73 inhibitors

April 5, 2022

Guangzhou Maxinovel Pharmaceuticals discloses PD-1/PD-L1 interaction inhibitors

April 5, 2022

Chengdu Origiant Pharmaceutical patents RIPK1 inhibitors

April 5, 2022

Novel carbazole derivatives attenuate mitochondrial function in models of lung adenocarcinoma

April 5, 2022

Allosteric regulators targeting GCase decrease toxic substrate accumulation in models of GD

April 5, 2022

Inhaled bispecific single-domain antibody neutralizes multiple SARS-CoV-2 variants

April 5, 2022

IRF3 orchestrates obesity-induced inflammation and dysglycemia

April 5, 2022

HCAR2 targeting modulates the progression of AD in mice

April 5, 2022

Molecular chaperone maintains proteostasis by clearing protein aggregates in cell

April 4, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Pharma industry faces long haul to get return on investment from AI
BioWorld Science
Artificial intelligence tools are springing up at multiple points along drug discovery and development, but despite the hype, as yet there is minimal return on...